Anabolic Steroids Change Opioid Peptide Levels in the Brain, Potentially Driving Aggression and Depression
Chronic nandrolone decanoate treatment altered enkephalin and dynorphin levels in multiple brain regions of rats, providing a neurochemical basis for the mood and personality changes seen in steroid abusers.
Quick Facts
What This Study Found
Chronic nandrolone treatment altered met-enkephalin and dynorphin concentrations in limbic and striatal brain regions, providing a neurochemical mechanism for steroid-associated mood and behavioral disturbances.
Key Numbers
How They Did This
Animal study. Rats received chronic nandrolone decanoate treatment. Regional brain opioid peptide concentrations (met-enkephalin, dynorphin) measured by radioimmunoassay in hypothalamus, striatum, periaqueductal gray, and other regions.
Why This Research Matters
Anabolic steroid abuse is widespread. Understanding the neurochemical basis of steroid-induced aggression and depression could help develop treatments and improve counseling for users.
The Bigger Picture
The opioid system regulates mood, reward, and aggression. Steroid-induced changes in this system create a neurochemical basis for "roid rage" and depression, connecting endocrine manipulation to psychiatric consequences.
What This Study Doesn't Tell Us
Rat study. Steroid doses may differ from human abuse patterns. Behavioral consequences of peptide changes were not directly measured. Correlation between peptide levels and specific behaviors not established.
Questions This Raises
- ?Can opioid system changes predict which steroid users develop psychiatric symptoms?
- ?Are the opioid peptide changes reversible after stopping steroids?
- ?Could opioid system modulators prevent steroid-related psychiatric effects?
Trust & Context
- Key Stat:
- Multiple brain regions Nandrolone altered both enkephalin and dynorphin in limbic and striatal areas that control mood, reward, and aggression
- Evidence Grade:
- Preliminary animal evidence with regional brain peptide measurements, providing neurochemical data relevant to steroid abuse psychiatry.
- Study Age:
- Published in 2000. The opioid system's role in steroid-related behavioral changes has been supported by subsequent research.
- Original Title:
- The effect on opioid peptides in the rat brain, after chronic treatment with the anabolic androgenic steroid, nandrolone decanoate.
- Published In:
- Brain research bulletin, 51(5), 413-8 (2000)
- Authors:
- Johansson, P, Hallberg, M, Kindlundh, A, Nyberg, F
- Database ID:
- RPEP-00596
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why do anabolic steroids cause mood changes?
This study shows steroids alter the brain's natural opioid system — the same system that regulates mood, pleasure, and aggression. Changes in enkephalin and dynorphin in emotion-regulating brain areas may drive the depression and aggression reported by users.
Is roid rage a real neurochemical phenomenon?
Based on this evidence, yes. Chronic anabolic steroids change opioid peptide levels in brain regions that control aggression and mood, providing a biological mechanism for the behavioral changes commonly called roid rage.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00596APA
Johansson, P; Hallberg, M; Kindlundh, A; Nyberg, F. (2000). The effect on opioid peptides in the rat brain, after chronic treatment with the anabolic androgenic steroid, nandrolone decanoate.. Brain research bulletin, 51(5), 413-8.
MLA
Johansson, P, et al. "The effect on opioid peptides in the rat brain, after chronic treatment with the anabolic androgenic steroid, nandrolone decanoate.." Brain research bulletin, 2000.
RethinkPeptides
RethinkPeptides Research Database. "The effect on opioid peptides in the rat brain, after chroni..." RPEP-00596. Retrieved from https://rethinkpeptides.com/research/johansson-2000-the-effect-on-opioid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.